Tech Company Financing Transactions
YonaLink Funding Round
YonaLink, operating out of Boston, raised $6 million from Debiopharm Innovation Fund, eHealth Ventures and European Union.
Transaction Overview
Company Name
Announced On
11/8/2022
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The investment will be used to bring more talent to the company's growing team, expand the YonaLink platform's capabilities, and drive its adoption among clinical trial sponsors and their clinical research organization (CRO) partners.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
One Lincoln Street 31st Floor
Boston, MA 02111
USA
Boston, MA 02111
USA
Phone
Website
Email Address
Overview
YonaLink was founded on the snowy streets of Toronto, Canada. What started out as a spark found between back-and-forth conversations, passing the time while running in a group on chilly winter nights, became a reason to meet up over cake, and mud-like Israeli coffee -- early mornings, late nights, and long weekends. Today, in the warmer confines of the Hadassah BIOHOUSE in Jerusalem, Israel, that spark has fostered a company that is changing the world of clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Iddo Peleg
Chief Operating Officer
Itai Rechnitz
Chief Technical Officer
Gil Meir
Co-Founder
Gav Martell
Browse more venture capital transactions:
Prev: 11/8/2022: Anzen venture capital transaction
Next: 11/8/2022: Revero venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs